Drawing for NEXALIN NEUROCARE

USPTO serial 99599704

NEXALIN NEUROCARE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MAROTTA, GABRIELLE CHRISTINA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with NEXALIN NEUROCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric L. Tanezaki

Eric L. Tanezaki STETINA GARRED BRUCKER & NEWBOLES75 Enterprise, Suite 250Aliso Viejo, CA 92656United States

Goods and services

ClassDescriptionStatusFirst use
010Electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulationACTIVE—
042providing a website featuring technology for healthcare professionals for managing and conducting remote medical examinations and consultations, for storing and managing electronic health records, physician documentation, healthcare data analytics, scheduling healthcare appointments, and for providing information to patients about personalized treatment plans and their medical conditions, healthcare services and healthcare providers, and for allowing patients and healthcare providers to communicate; providing a website featuring technology that analyzes data from electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulation and enables the user to access and upload data from electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulation; Software as a service (SaaS) services featuring software for healthcare professionals for managing and conducting remote medical examinations and consultations, for storing and managing electronic health records, physician documentation, healthcare data analytics, scheduling healthcare appointments, and providing information to patients about personalized treatment plans and their medical conditions, healthcare services and healthcare providers, and for allowing patients and healthcare providers to communicate; Software as a service (SaaS) services featuring software that analyzes data from electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulation and enables the user to access and upload data from electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulationACTIVE—
044providing telehealth services being remote healthcare services; telemedicine servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Aug 4, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 9, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2026XAECEXAMINER'S AMENDMENT ENTERED—
May 15, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 15, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
May 15, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2026DOCKASSIGNED TO EXAMINER—
May 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance